FDA Inspection 1090850 — Etex Corporation

Etex Corporation — FEI 3000206397

The FDA completed an inspection of Etex Corporation on May 23, 2019 in Braintree, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 23, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Braintree, MA (United States)

Citations

IDCFRDescription
1223721 CFR 1271.55(a)(3)Summary--records used to make determination